Michail E. Kalaitzakis

1.3k total citations
13 papers, 947 citations indexed

About

Michail E. Kalaitzakis is a scholar working on Neurology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michail E. Kalaitzakis has authored 13 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 7 papers in Physiology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michail E. Kalaitzakis's work include Parkinson's Disease Mechanisms and Treatments (11 papers), Alzheimer's disease research and treatments (7 papers) and Neurological disorders and treatments (5 papers). Michail E. Kalaitzakis is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (11 papers), Alzheimer's disease research and treatments (7 papers) and Neurological disorders and treatments (5 papers). Michail E. Kalaitzakis collaborates with scholars based in United Kingdom, Belgium and Australia. Michail E. Kalaitzakis's co-authors include R. K. B. Pearce, Steve Gentleman, Manuel B. Graeber, Linda Moran, Stephen M. Gentleman, W. Sue T. Griffin, Dawn Duke, David T. Dexter, Manuel Deprez and Gregory J. Michael and has published in prestigious journals such as SHILAP Revista de lepidopterología, Acta Neuropathologica and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

Michail E. Kalaitzakis

13 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michail E. Kalaitzakis United Kingdom	12	646	299	241	210	166	13	947
Karin D. van Dijk Netherlands	14	589 0.9×	289 1.0×	168 0.7×	165 0.8×	159 1.0×	21	923
Jiehao Zhao China	17	447 0.7×	121 0.4×	144 0.6×	142 0.7×	87 0.5×	23	704
Silvia Eshuis Netherlands	6	613 0.9×	136 0.5×	281 1.2×	93 0.4×	112 0.7×	8	907
Virginia Gao United States	12	370 0.6×	203 0.7×	378 1.6×	260 1.2×	246 1.5×	18	1.1k
R. Hilker Germany	16	701 1.1×	125 0.4×	346 1.4×	91 0.4×	137 0.8×	25	1.1k
Daniele Sandmann-Keil Germany	7	812 1.3×	243 0.8×	380 1.6×	202 1.0×	194 1.2×	8	1.1k
Adam Chen United States	7	401 0.6×	101 0.3×	123 0.5×	192 0.9×	141 0.8×	13	760
Lorenzo Kiferle Italy	20	871 1.3×	112 0.4×	551 2.3×	221 1.1×	196 1.2×	30	1.3k
Masamichi Yokokura Japan	16	246 0.4×	269 0.9×	300 1.2×	359 1.7×	248 1.5×	29	906
Shunnan Ge China	17	280 0.4×	123 0.4×	268 1.1×	159 0.8×	235 1.4×	55	805

Countries citing papers authored by Michail E. Kalaitzakis

Since Specialization

Citations

This map shows the geographic impact of Michail E. Kalaitzakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michail E. Kalaitzakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michail E. Kalaitzakis more than expected).

Fields of papers citing papers by Michail E. Kalaitzakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michail E. Kalaitzakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michail E. Kalaitzakis. The network helps show where Michail E. Kalaitzakis may publish in the future.

Co-authorship network of co-authors of Michail E. Kalaitzakis

This figure shows the co-authorship network connecting the top 25 collaborators of Michail E. Kalaitzakis. A scholar is included among the top collaborators of Michail E. Kalaitzakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michail E. Kalaitzakis. Michail E. Kalaitzakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Liu, Alan King Lun, Tsz Wing Chau, Ernest Lim, et al.. (2019). Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline. Acta Neuropathologica Communications. 7(1). 61–61. 52 indexed citations

Vlachos, George S., et al.. (2015). A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer’s disease treated with rivastigmine transdermal patch. SHILAP Revista de lepidopterología. 3. 2102659795–2102659795. 4 indexed citations

Kalaitzakis, Michail E., et al.. (2014). Phenotypic profile of alternative activation marker CD163 is different in Alzheimer’s and Parkinson’s disease. Acta Neuropathologica Communications. 2(1). 21–21. 89 indexed citations

Kalaitzakis, Michail E., Steve Gentleman, & R. K. B. Pearce. (2013). Disturbed sleep in Parkinson's disease: anatomical and pathological correlates. Neuropathology and Applied Neurobiology. 39(6). 644–653. 62 indexed citations

Kalaitzakis, Michail E., et al.. (2010). Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes. Neurobiology of Disease. 41(2). 377–384. 54 indexed citations

Kalaitzakis, Michail E., R. K. B. Pearce, & Steve Gentleman. (2009). Clinical correlates of pathology in the claustrum in Parkinson's disease and dementia with Lewy bodies. Neuroscience Letters. 461(1). 12–15. 46 indexed citations

Kalaitzakis, Michail E. & R. K. B. Pearce. (2009). The morbid anatomy of dementia in Parkinson’s disease. Acta Neuropathologica. 118(5). 587–598. 73 indexed citations

Kalaitzakis, Michail E., et al.. (2008). Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease. Parkinsonism & Related Disorders. 15(3). 196–204. 115 indexed citations

Kalaitzakis, Michail E., Manuel B. Graeber, Stephen M. Gentleman, & R. K. B. Pearce. (2008). Striatal β-Amyloid Deposition in Parkinson Disease With Dementia. Journal of Neuropathology & Experimental Neurology. 67(2). 155–161. 109 indexed citations

10.

Moran, Linda, et al.. (2007). Neuronal pentraxin II is highly upregulated in Parkinson’s disease and a novel component of Lewy bodies. Acta Neuropathologica. 115(4). 471–478. 61 indexed citations

11.

Kalaitzakis, Michail E., Manuel B. Graeber, Steve Gentleman, & R. K. B. Pearce. (2007). The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of α‐synuclein staging. Neuropathology and Applied Neurobiology. 34(3). 284–295. 173 indexed citations

12.

Moran, Linda, Emilie Croisier, Dawn Duke, et al.. (2007). Analysis of alpha-synuclein, dopamine and parkin pathways in neuropathologically confirmed parkinsonian nigra. Acta Neuropathologica. 113(3). 253–263. 36 indexed citations

13.

Duke, Dawn, Linda Moran, Michail E. Kalaitzakis, et al.. (2006). Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson’s disease. Neurogenetics. 7(3). 139–148. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact